Corpus Intelligence IC Memo — GEORGE COUNTY HOSPITAL 2026-04-26 03:42 UTC
IC Memo — GEORGE COUNTY HOSPITAL
Investment Committee Memorandum | MS | 39 beds | Grade D | EBITDA uplift $3.1M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

GEORGE COUNTY HOSPITAL

CCN 250036 | GEORGE, MS | 39 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

GEORGE COUNTY HOSPITAL is a 39-bed safety-net/medicaid heavy in GEORGE, MS with $42.1M in net patient revenue and a -5.4% operating margin. The hospital serves a payer mix of 26.1% Medicare, 29.2% Medicaid, and 44.7% commercial.

Thesis: Turnaround. Our ML models identify $3.1M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -5.4% to 2.0% (+736bps).

Net Revenue HCRIS$42.1M
Current EBITDA COMPUTED$-2.3M
Operating Margin COMPUTED-5.4%
Occupancy HCRIS23.8%
Revenue / Bed COMPUTED$1.1M
Net-to-Gross HCRIS51.3%
Distress Probability ML62.5%

2. Market Context & Competitive Position

110
MS Hospitals
-12.5%
State Median Margin
65
Comparable Hospitals

MS has 110 Medicare-certified hospitals with a median operating margin of -12.5%. The target's margin of -5.4% places it above the state median. Among 65 size-comparable peers (20-78 beds), the median margin is -14.9%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (20-78), prioritizing same-state peers. 65 hospitals in the comp set.

HospitalStateBedsRevenueMargin
GEORGE COUNTY HOSPITAL (Target)MS39$42.1M-5.4%
KINGS DAUGHTERS MEDICAL CENTERMS22$91.5M-8.4%
METHODIST H/C OLIVE BRANCH HOSMS65$75.4M-25.6%
NORTH SUNFLOWER COUNTY HOSPITAMS25$70.1M-7.2%
MISSISSIPPI METHODIST REHAB CEMS31$68.1M-0.5%
UMMC-GRENADAMS49$63.7M7.1%
NESHOBA COUNTY GENERAL HOSPITAMS38$47.6M-19.7%
MONROE REGIONAL HOSPITALMS25$45.6M0.9%
CLAY COUNTY MEDICAL CORPORATIOMS49$45.4M0.5%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $3.1M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$883K+210bp18mo
Cost to Collect4.5%2.5%$841K+200bp12mo
Denial Rate Reduction12.0%6.5%$833K+198bp12mo
A/R Days Reduction5200.0%3800.0%$512K+122bp9mo
Clean Claim Rate88.0%96.0%$27K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$883K
Cost to Collect
$841K
Denial Rate Reduction
$833K
A/R Days Reduction
$512K
Clean Claim Rate
$27K
Total EBITDA Uplift$3.1M
Current EBITDA$-2.3M
+ RCM Uplift+$3.1M
Pro Forma EBITDA$841K
Current Margin-5.4%
Pro Forma Margin2.0%
WC Released (1x)$1.6M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-3.5M$16.1M0.00x-100.0%
Base (11x exit)10.0x11.0x$-3.5M$16.6M0.00x-100.0%
Bull Case9.0x11.0x$-3.1M$25.7M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-3.1M$27.1M0.00x-100.0%
Bear Case11.0x10.0x$-3.8M$1.7M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-3.8M$665K0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumElevated Medicaid exposure (29.2%)Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims
MediumLow occupancyAt 23.8%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 62.5% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 65 hospitals with 20-78 beds
  • Same-state prioritization (n=66)
  • Comp margins: P25=-25.5% / P50=-14.9% / P75=-2.5%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.